Issam Raad

Active 1990–2025

166
Papers
43,467
Citations
99
h-index
163
i10-index

Citations

Citations per year for Issam Raad1989: 3 citations1992: 11 citations1993: 12 citations1994: 9 citations1995: 28 citations1996: 43 citations1997: 45 citations1998: 62 citations1999: 96 citations2000: 81 citations2001: 151 citations2002: 226 citations2003: 228 citations2004: 298 citations2005: 296 citations2006: 328 citations2007: 426 citations2008: 443 citations2009: 410 citations2010: 418 citations2011: 363 citations2012: 354 citations2013: 332 citations2014: 387 citations2015: 245 citations2016: 291 citations2017: 253 citations2018: 206 citations2019: 806 citations2020: 754 citations2021: 591 citations2022: 424 citations2023: 325 citations2024: 514 citations2025: 214 citations2026: 6 citations1990–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,734 citing papers, 28.1% of this breakdownUnited Kingdom: 548 citing papers, 5.6% of this breakdownItaly: 489 citing papers, 5% of this breakdownFrance: 473 citing papers, 4.9% of this breakdownGermany: 453 citing papers, 4.7% of this breakdownSpain: 434 citing papers, 4.5% of this breakdownChina: 368 citing papers, 3.8% of this breakdownAustralia: 355 citing papers, 3.6% of this breakdownCanada: 291 citing papers, 3% of this breakdownNetherlands: 272 citing papers, 2.8% of this breakdownSwitzerland: 260 citing papers, 2.7% of this breakdownBelgium: 219 citing papers, 2.2% of this breakdown
0%28.1%Other 29.1%

Fields

  • Medicine62.5%
  • Health Professions18.6%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Immunology and Microbiology2.3%
  • Nursing1%
  • Engineering0.8%
  • Other3.9%

Topics

  • Antifungal resistance and susceptibility10.4%
  • Fungal Infections and Studies7.2%
  • Central Venous Catheters and Hemodialysis7%
  • Neutropenia and Cancer Infections4%
  • Nosocomial Infections in ICU3.5%
  • Antimicrobial Resistance in Staphylococcus2.9%
  • Other65%

Coauthors

All papers

Open in search
  1. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2009 cited by 3,609

  2. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2015 cited by 972

  3. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2011 cited by 3,427

  4. Guidelines for the Prevention of Intravascular Catheter-related Infections

    Authors: , , , , , , , , , , , , , - American Journal of Infection Control 2011 cited by 4,659

  5. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 276

  6. Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive Pathogens

    Authors: , , , , , , , , - Clinical Infectious Diseases 2005 cited by 295

  7. Summary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2011 cited by 563

  8. Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2011 cited by 706

  9. Guidelines for the Management of Intravascular Catheter-Related Infections

    Authors: , , , , , , - Clinical Infectious Diseases 2001 cited by 1,455

  10. Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

    Authors: , , , , , , , , , , - The Journal of Infectious Diseases 2005 cited by 677

  11. Posaconazole: a broad-spectrum triazole antifungal

    Authors: , , , , - The Lancet Infectious Diseases 2005 cited by 285

  12. Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2006 cited by 750

  13. Biofilm-Based Central Line-Associated Bloodstream Infections

    Authors: , , - Advances in experimental medicine and biology 2014 cited by 100

  14. Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

    Authors: , , , , , - Antimicrobial Agents and Chemotherapy 2020 cited by 56

  15. Ultrastructural Analysis of Indwelling Vascular Catheters: A Quantitative Relationship between Luminal Colonization and Duration of Placement

    Authors: , , , , , - The Journal of Infectious Diseases 1993 cited by 552

  16. Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm

    Authors: , , , , , , , - Antimicrobial Agents and Chemotherapy 2007 cited by 346

  17. Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients

    Authors: , , , , , , , , , - Medicine 2006 cited by 330

  18. International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole

    Authors: , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2010 cited by 181

  19. Candida krusei Fungemia

    Authors: , , , , , , , , - Archives of Internal Medicine 2000 cited by 175

  20. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients

    Authors: , , , , , , , , - Cancer 2006 cited by 79

  21. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period

    Authors: , , , , , , , , , , , , , , , , , , , - eLife 2023 cited by 42

  22. Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer

    Authors: , , , , , , , - Journal of Fungi 2021 cited by 35

  23. Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study

    Authors: , , , , , , , , , - Journal of Fungi 2023 cited by 23

  24. Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2004 cited by 662